|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_NoncurrentFinancialAssetAcquisitionAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
March 16, 2022
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_BoardDecisionDateForAcquisition|
|
|
20/05/2022
|
|||||||
|
oda_WereMajorityOfIndependentBoardMembersApprovedTheBoardDecisionForAcquisition|
|
|
50.00% signed.
|
|||||||
|
oda_TitleOfNoncurrentFinancialAssetAcquired|
|
|
MS Sağlık Hizmetleri Ticaret A.Ş.
|
|||||||
|
oda_FieldOfActivityNoncurrentFinancialAssetWhoseSharesWereAcquired|
|
|
Hospital Services
|
|||||||
|
oda_CapitalOfNoncurrentFinancialAsset|
|
|
TL 1,000,000.00
|
|||||||
|
oda_AcquirementWay|
|
|
Devralma (Takeover)
|
|||||||
|
oda_DateOnWhichTheTransactionWasWillBeCompleted|
|
|
May 20, 2022
|
|||||||
|
oda_AcquisitionConditions|
|
|
Peşin (Cash)
|
|||||||
|
oda_DetailedConditionsIfItIsATimedPayment|
|
|
It is not a Timed Payment.
|
|||||||
|
oda_NominalValueOfSharesAcquired|
|
|
TL 250,000.00
|
|||||||
|
oda_PurchasePricePerShare|
|
|
TL 1.00
|
|||||||
|
oda_TotalPurchasingValue|
|
|
TL 250,000.00
|
|||||||
|
oda_RatioOfNewSharesAcquiredToCapitalOfNoncurrentFinancialAsset|
|
|
25.00%
|
|||||||
|
oda_TotalRatioOfSharesOwnedInCapitalOfNoncurrentFinancialAssetAfterTransaction|
|
|
100.00%
|
|||||||
|
oda_TotalVotingRightRatioOwnedInNoncurrentFinancialAssetAfterTransaction|
|
|
100.00%
|
|||||||
|
oda_RatioOfNoncurrentFinancialAssetAcquiredToTotalAssetsInLatestDisclosedFinancialStatementsOfCompany|
|
|
0.004%
|
|||||||
|
oda_RatioOfTransactionValueToSalesInLatestAnnualFinancialStatementsOfCompany|
|
|
0.37%
|
|||||||
|
oda_EffectsOnCompanyOperations|
|
|
There is no significant effect. Under MS Sağlık Hizmetleri Ticaret A.Ş. (MS Sağlık) subsidiary Liv Hospital Ankara is operated. MLP Care's shareholding percentage in MS Sağlık increased from 75.00% to 100.00%.
|
|||||||
|
oda_DidTakeoverBidObligationArised|
|
|
Hayır (No)
|
|||||||
|
oda_WillExemptionApplicationBeMadeIfTakeoverBidObligationArised|
|
|
Hayır (No)
|
|||||||
|
oda_TitleNameSurnameOfCounterParty|
|
|
MP Sağlık ve Ticaret A.Ş.
|
|||||||
|
oda_IsCounterPartyARelatedPartyAccordingToCMBRegulations|
|
|
Hayır (No)
|
|||||||
|
oda_RelationWithCounterPartyIfAny|
|
|
None.
|
|||||||
|
oda_AgreementSigningDateIfExists|
|
|
16/03/2022
|
|||||||
|
oda_ValueDeterminationMethodOfNoncurrentFinancialAsset|
|
|
Valuation Report
|
|||||||
|
oda_DidValuationReportBePrepared|
|
|
Düzenlendi (Prepared)
|
|||||||
|
oda_ReasonForNotPreparingValuationReportIfItWasNotPrepared|
|
|
None.
|
|||||||
|
oda_DateAndNumberOfValuationReport|
|
|
Report Dated on March 25, 2022
|
|||||||
|
oda_TitleOfValuationCompanyPreparedReport|
|
|
KPMG Yönetim Danışmanlığı A.Ş.
|
|||||||
|
oda_ValueDeterminedInValuationReportIfExists|
|
|
The fair value of the Liv Hospital Ankara is calculated between TL 96,000,000.00 and TL 169,000,000.00, with a midpoint of TL 130,000,000.00. The related purchase transaction is for the acquisition of 25.00% of MS Sağlık shares.
|
|||||||
|
oda_ReasonsIfTransactionWasntWillNotBePerformedInAccordanceWithValuationReport|
|
|
None.
|
|||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
The share transfer process, which started on March 16, 2022 with the share transfer agreement regarding two of the subsidiaries (Sentez and MS Sağlık) between MLP Sağlık Hizmetleri A.Ş. (MLP Care) and MP Sağlık ve Ticaret A.Ş. (MP Sağlık), was completed on May 20, 2022. The Non-Current Financial Asset Sale and Non-Current Financial Asset Acquisition transactions detailed above are considered below the limits set in article 6 Significance criterion of the Capital Markets Board's II-23.3 Common Principles Regarding Material Transactions and the Right to Leave (CMB Communique II-23.3). This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail. |
||||||||